Mingwei Chen

1.8k total citations · 1 hit paper
72 papers, 1.3k citations indexed

About

Mingwei Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mingwei Chen has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Mingwei Chen's work include Lung Cancer Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Mingwei Chen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Cancer-related molecular mechanisms research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Mingwei Chen collaborates with scholars based in China, Australia and United States. Mingwei Chen's co-authors include Xiang Bu, Linyan Wei, Jing Liu, Xiqiang Wang, Hui Ren, Hui Ren, Zhonglei Xie, Yang Tian, Xiaomin Dang and Tianjun Chen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Mingwei Chen

66 papers receiving 1.3k citations

Hit Papers

Global PM2.5-attributable health burden from 1990 to 2017... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingwei Chen China 18 643 279 268 232 176 72 1.3k
Jer‐Hwa Chang Taiwan 19 435 0.7× 236 0.8× 216 0.8× 324 1.4× 180 1.0× 66 1.5k
Biao Zhang China 22 594 0.9× 252 0.9× 225 0.8× 126 0.5× 168 1.0× 65 1.5k
Courtney A. Granville United States 16 692 1.1× 214 0.8× 207 0.8× 131 0.6× 276 1.6× 22 1.3k
Rui Zhou China 20 329 0.5× 149 0.5× 154 0.6× 299 1.3× 123 0.7× 72 1.1k
Huizhen Sun China 18 458 0.7× 189 0.7× 352 1.3× 137 0.6× 383 2.2× 41 1.2k
Hao Zheng China 22 433 0.7× 109 0.4× 153 0.6× 124 0.5× 157 0.9× 68 1.4k
Mengge Zhou China 15 576 0.9× 397 1.4× 217 0.8× 168 0.7× 131 0.7× 38 2.0k
Hairong Bao China 16 231 0.4× 193 0.7× 234 0.9× 288 1.2× 210 1.2× 62 948
Ivana Holcátová Czechia 20 505 0.8× 265 0.9× 336 1.3× 290 1.3× 158 0.9× 40 1.3k
Sylvie Cénée France 23 331 0.5× 213 0.8× 252 0.9× 293 1.3× 273 1.6× 55 1.3k

Countries citing papers authored by Mingwei Chen

Since Specialization
Citations

This map shows the geographic impact of Mingwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Chen more than expected).

Fields of papers citing papers by Mingwei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Chen. The network helps show where Mingwei Chen may publish in the future.

Co-authorship network of co-authors of Mingwei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingwei Chen. A scholar is included among the top collaborators of Mingwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingwei Chen. Mingwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Kailong, Zhen Ding, Guang Hu, et al.. (2025). Study on the sulfur fixation mechanism of high-entropy ceramic Li0.3(Mg0.2Co0.2Ni0.2Cu0.2Zn0.2)0.85O for lithium–sulfur batteries. Journal of Materials Science Materials in Electronics. 36(33).
2.
Luo, Xiaoqing, Jing Liu, Yan Sun, et al.. (2024). AOPPs induces EMT and fibrosis by activating oxidative stress through ERK/p38 MAPK signaling pathway in endometriosis. Reproductive Biology. 24(4). 100950–100950. 7 indexed citations
3.
Wang, Jie, Jie Zhou, Chunhui Jiang, et al.. (2024). Araloside A alleviates sepsis-induced acute lung injury via PHD2/HIF-1α in macrophages. Phytomedicine. 135. 156089–156089. 4 indexed citations
4.
Li, Wenrui, et al.. (2024). The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study. Frontiers in Endocrinology. 15. 1440941–1440941. 1 indexed citations
5.
Chen, Mingwei, et al.. (2023). Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study. Frontiers in Pharmacology. 14. 1224737–1224737. 2 indexed citations
6.
Zhang, Chan, et al.. (2023). IL1RL1 polymorphisms rs12479210 and rs1420101 are associated with increased lung cancer risk in the Chinese Han population. Frontiers in Genetics. 14. 1183528–1183528. 3 indexed citations
7.
Zhang, Kun, et al.. (2023). Bioinformatics and computational chemistry approaches to explore the mechanism of the anti-depressive effect of ligustilide. Scientific Reports. 13(1). 5417–5417. 6 indexed citations
8.
Xu, Pan, Bo Liu, Rongrong Li, et al.. (2022). MOBT Alleviates Pulmonary Fibrosis through an lncITPF–hnRNP-l-Complex-Mediated Signaling Pathway. Molecules. 27(16). 5336–5336. 2 indexed citations
9.
Shi, Yuankai, Xin Zhang, Gang Wu, et al.. (2022). Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study. The Lancet Regional Health - Western Pacific. 23. 100452–100452. 10 indexed citations
10.
Zhang, Chan, et al.. (2022). Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer. Current Cancer Drug Targets. 25(12). 1568–1577. 3 indexed citations
12.
Sun, Yan, Fenglin Xu, Meng Li, et al.. (2022). Cost-effectiveness of lung cancer screening combined with nurse-led smoking cessation intervention: A population-based microsimulation study. International Journal of Nursing Studies. 134. 104319–104319. 2 indexed citations
13.
Bu, Xiang, Zhonglei Xie, Jing Liu, et al.. (2021). Global PM2.5-attributable health burden from 1990 to 2017: Estimates from the Global Burden of disease study 2017. Environmental Research. 197. 111123–111123. 206 indexed citations breakdown →
14.
Bu, Xiang, Jing Liu, Linyan Wei, Xiqiang Wang, & Mingwei Chen. (2020). Epidemiological features and survival outcomes in patients with malignant pulmonary blastoma: a US population-based analysis. BMC Cancer. 20(1). 811–811. 12 indexed citations
16.
Zhang, Shuo, Guoqing Qian, Qianqian Zhang, et al.. (2019). mTORC2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis. Cancer Research. 79(14). 3725–3736. 22 indexed citations
17.
Tian, Yang, Hong Li, Tianjun Chen, et al.. (2019). LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis.. Europe PMC (PubMed Central). 42(3). 270–283. 69 indexed citations
18.
Zhang, Anna, et al.. (2015). ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy. Current Drug Targets. 16(12). 1356–1371. 68 indexed citations
19.
Liang, Yiqian, Tianran Ma, Asmitananda Thakur, et al.. (2014). Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer. Glycobiology. 25(3). 331–340. 60 indexed citations
20.
Ren, Hui, Junghui Koo, Baoxiang Guan, et al.. (2013). The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis. Molecular Cancer. 12(1). 146–146. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026